Latest Breaking News On - Both innate - Page 1 : comparemela.com

SHANGHAI and GAITHERSBURG, Md., March 9, 2022 /PRNewswire/ I-Mab (the Company ) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company com.

United statesHong kongSan diegoXuejun liuAndrew zhuJian liExchange commissionAmerican association for cancer researchPrnewswire the company nasdaqAmerican associationCancer researchBoth innateAdaptive immunityNovel claudinPrivate securities litigation reform act